Teppei Sasahara
Overview
Explore the profile of Teppei Sasahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogawa M, Ae R, Sasahara T, Omi K
BMC Nurs
. 2024 Oct;
23(1):724.
PMID: 39379883
Background: New employees often exhibit stress reactions to changes in their environment and some of these may result in resignations. Employees in medical institutions are no exceptions. Considering the shortage...
2.
Cui L, Watanabe S, Miyanaga K, Kiga K, Sasahara T, Aiba Y, et al.
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39335043
Phage therapy, the use of bacteriophages (phages) to treat bacterial infections, is regaining momentum as a promising weapon against the rising threat of multidrug-resistant (MDR) bacteria. This comprehensive review explores...
3.
Akine D, Sasahara T, Hirota Y, Kato H
Am J Trop Med Hyg
. 2024 Sep;
111(5):953-955.
PMID: 39293421
Leishmaniasis is caused by an obligate intracellular protozoa of the genus Leishmania. Its clinical manifestations include cutaneous, mucocutaneous, and visceral forms. Sporotrichoid cutaneous leishmaniasis (SCL) is an atypical and rare...
4.
Li F, Tan X, Shimamori Y, Kiga K, Veeranarayanan S, Watanabe S, et al.
Commun Biol
. 2024 Sep;
7(1):1129.
PMID: 39271957
In response to the escalating antibiotic resistance in multidrug-resistant pathogens, we propose an innovative phagemid-based capsid system to generate CRISPR-Cas13a-loaded antibacterial capsids (AB-capsids) for targeted therapy against multidrug-resistant Staphylococcus aureus....
5.
Shimamori Y, Tan X, Li F, Nishikawa Y, Watanabe S, Sasahara T, et al.
Sci Rep
. 2024 Jul;
14(1):16225.
PMID: 39003336
In response to the escalating global threat of antimicrobial resistance, our laboratory has established a phagemid packaging system for the generation of CRISPR-Cas13a-antimicrobial capsids targeting methicillin-resistant Staphylococcus aureus (MRSA). However,...
6.
Watanabe S, Nsofor C, Thitiananpakorn K, Tan X, Aiba Y, Takenouchi R, et al.
mBio
. 2024 Jul;
15(6):e0033924.
PMID: 38988221
Importance: The emergence of oxacillin-susceptible methicillin-resistant (OS-MRSA) strains has created new challenges for treating MRSA infections. These strains can become resistant to β-lactam antibiotics through chromosomal mutations, including those in...
7.
Suzuki J, Endo S, Suzuki T, Sasahara T, Hatakeyama S, Morisawa Y, et al.
Open Forum Infect Dis
. 2023 Dec;
10(12):ofad571.
PMID: 38075018
Background: Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic. Although systemic steroids play an important role in treating patients with severe COVID-19, the role of inhaled corticosteroids in non-critically...
8.
Nawa H, Akine D, Tamura T, Saito K, Kaburagi T, Sasahara T
J Gen Fam Med
. 2023 Nov;
24(6):350-351.
PMID: 38025929
An 88-year-old man was treated with high-dose systemic steroid therapy for COVID-19 and idiopathic interstitial pneumonia months before admission to the hospital because of swelling and redness in his left...
9.
Ishibashi H, Sasahara T, Katagiri O, Yamada T
Intern Med
. 2023 Aug;
63(6):887-888.
PMID: 37532542
No abstract available.
10.
Nakamura Y, Matsubara Y, Kosami K, Ae R, Sasahara T, Aoyama Y, et al.
Pediatr Int
. 2022 Oct;
64(1):e15268.
PMID: 36257613
Background: The long-term prognosis of those with a history of Kawasaki disease (KD) is still unknown. Methods: Using a permanent registry system in Japan (koseki), 6,576 persons with a history...